ArticleFrontiers in immunology2024

Combination of JAK inhibitor and immune checkpoint inhibitor in clinical trials: a breakthrough.

Shiqing Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.